Latest KFF Health News Stories
KHN’s ‘What the Health?’: The Politics of Vaccine Mandates
Like almost everything else associated with the covid-19 pandemic, partisans are taking sides over whether vaccines should be mandated. Meanwhile, Democrats on Capitol Hill are still struggling to find compromise in their effort to expand health insurance and other social programs. Alice Miranda Ollstein of Politico, Jen Haberkorn of the Los Angeles Times and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews best-selling author Beth Macy about her book “Dopesick,” and the new Hulu miniseries based on it.
Surprise-Billing Rule ‘Puts a Thumb on the Scale’ to Keep Arbitrated Costs in Check
Patients soon will not have to worry about the prospect of these often-costly unexpected bills, a federal law promises. Some experts say the new policy could also slow the growth of health insurance premiums.
The Public Backs Medicare Rx Price Negotiation Even After Hearing Both Sides’ Views
But Americans generally have little confidence that the White House or Congress will recommend the right thing, a new poll shows.
‘An Arm and a Leg’: How One State Protects Patients From Hospital Lawsuits
In Maryland, it’s now illegal for a hospital to sue a patient who qualifies for charity care. But in many other states, that’s still a thing.
Youthful Advisers Help Shape a Mental Health Program for Their Peers
Officials are enthusiastic about the Allcove initiative, modeled on an Australian program. But it will need to show effectiveness and find funding.
What the Stalemate on Capitol Hill Means for Your Drug Prices
Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan.
KHN’s ‘What the Health?’: The Health Agenda Still on Hold
Negotiations continue on Capitol Hill over President Joe Biden’s health agenda — along with a long list of other items. With Republicans on the sidelines, liberal Democrats delayed a House vote on a Senate-passed infrastructure bill to extract moderates’ support for a social-spending bill that includes expansions of benefits for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the Biden administration’s new rules to prevent “surprise” medical bills pleases some health stakeholders and angers others. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Kimberly Leonard of Insider join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Anna Flagg of the Marshall Project about how a century-old report on medical education contributed to racial inequities that persist today.
Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
These Schools Use Weekly Testing to Keep Kids in Class — And Covid Out
Coronavirus outbreaks have shuttered K-12 classrooms across the U.S., affecting tens of thousands of K-12 students. To avoid the same fate, some school districts are tapping federal dollars to set up testing programs and step up their vigilance against the virus.
KHN’s ‘What the Health?’: The Autumn of Democrats’ Discontent
Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden’s entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.
The Solution to Au Pairs’ Health Coverage Gaps May Be Simple: ACA Plans
Private agencies that bring young adults to the U.S. to care for children generally offer basic health insurance, but plans may exclude many types of necessary care. What the agencies might not mention is that au pairs are eligible to enroll in comprehensive coverage on the Affordable Care Act marketplaces and likely qualify for premium subsidies that would make the insurance affordable.
‘An Arm and a Leg’: They Turned Grief Into Action
This episode highlights how New York enacted a charity care law, one of the precursors to the federal provision on charity care in the Affordable Care Act.
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
Justice Department Targets Data Mining in Medicare Advantage Fraud Case
The feds’ civil suit links exaggerated patient bills to “tens of millions” in overcharges.
Why At-Home Rapid Covid Tests Cost So Much, Even After Biden’s Push for Lower Prices
Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.
KHN’s ‘What the Health?’: The Future of Public Health
The covid pandemic has spotlighted the often-unseen role of public health in Americans’ daily lives. And the picture has not all been pretty. What is public health and why is it so important — and controversial? Dr. Ashish Jha, dean of the Brown University School of Public Health, explains the basics. Then, Joanne Kenen of Politico and Lauren Weber of KHN join KHN’s Julie Rovner to discuss what could happen next.
‘An Arm and a Leg’: How Charity Care Made It Into the ACA
In this episode, we hear how the political tango over guaranteeing that nonprofit hospitals provide charity care nearly tanked the Affordable Care Act — and how the battle over the ACA “broke America.”
Florida Spine Surgeon and Device Company Owner Charged in Kickback Scheme
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
V-Safe: How Everyday People Help the CDC Track Covid Vaccine Safety With Their Phones
V-safe is a new safety monitoring system that lets anyone who has been vaccinated against covid-19 report possible side effects directly to federal health officials. Experts believe the smartphone tool has so far helped demonstrate the vaccines are safe.
